DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

SVB Leerink Maintains Outperform on Aduro Biotech, Raises Price Target to $7

SVB Leerink maintains Aduro Biotech (NASDAQ:ADRO) with a Outperform and raises the price target from $3 to $7.

Benzinga · 01/31/2020 13:46

SVB Leerink maintains Aduro Biotech (NASDAQ:ADRO) with a Outperform and raises the price target from $3 to $7.